Abbott Laboratories
ABT
#101
Rank
NZ$340.79 B
Marketcap
NZ$196.77
Share price
-0.81%
Change (1 day)
-11.79%
Change (1 year)
Categories

Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.

Market capitalization of Abbott Laboratories (ABT)

Market cap: NZ$340.79 Billion

As of November 2026 Abbott Laboratories has a market cap of NZ$340.79 Billion. This makes Abbott Laboratories the world's 101th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Abbott Laboratories from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$340.79 B-9.16%
2025NZ$375.16 B6.09%
2024NZ$353.64 B17.04%
2023NZ$302.16 B0.22%
2022NZ$301.50 B-17.25%
2021NZ$364.35 B35.47%
2020NZ$268.94 B18.32%
2019NZ$227.31 B20.07%
2018NZ$189.31 B35.35%
2017NZ$139.87 B71.32%
2016NZ$81.64 B-15.52%
2015NZ$96.63 B11.52%
2014NZ$86.65 B20%
2013NZ$72.20 B-42.48%
2012NZ$125.53 B11.85%
2011NZ$112.23 B16.83%
2010NZ$96.06 B-16.68%
2009NZ$115.30 B-19.2%
2008NZ$142.69 B25.6%
2007NZ$113.61 B6.89%
2006NZ$106.28 B19.7%
2005NZ$88.79 B-12.94%
2004NZ$101.98 B-9.48%
2003NZ$112.67 B-6.12%
2002NZ$120.02 B-42.76%
2001NZ$209.68 B24.09%
2000NZ$168.97 B57.19%
1999NZ$107.49 B-23.74%
1998NZ$140.96 B63.44%
1997NZ$86.24 B53.14%
1996NZ$56.31 B

End of Day market cap according to different sources

On Nov 10th, 2026 the market cap of Abbott Laboratories was reported to be:

NZ$343.55 Billion
by Nasdaq info icon info icon
NZ$343.57 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$1.198 T 251.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$541.29 B 58.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$298.54 B-12.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$230.42 B-32.38%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
NZ$480.55 B 41.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$116.41 B-65.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$30.47 B-91.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$225.30 B-33.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$512.24 B 50.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$179.54 B-47.32%๐Ÿ‡ฌ๐Ÿ‡ง UK